D
Daryl Gress
Researcher at University of Nebraska Medical Center
Publications - 5
Citations - 578
Daryl Gress is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Stroke & Clinical trial. The author has an hindex of 4, co-authored 5 publications receiving 487 citations.
Papers
More filters
Journal ArticleDOI
Spinal manipulative therapy is an independent risk factor for vertebral artery dissection.
Wade S. Smith,S. C. Johnston,Elaine Skalabrin,Michael J. Weaver,P. Azari,Gregory W. Albers,Daryl Gress +6 more
TL;DR: This case-controlled study of the influence of SMT and cervical arterial dissection shows that SMT is independently associated with vertebral arterials dissection, even after controlling for neck pain.
Journal ArticleDOI
Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods:
Tudor G Jovin,Jeffrey L. Saver,Marc Ribó,Vitor Mendes Pereira,Anthony J. Furlan,Alain Bonafe,Blaise Baxter,Rishi Gupta,Demetrius K. Lopes,Olav Jansen,Wade S. Smith,Daryl Gress,Steven W. Hetts,Roger J. Lewis,Ryan K. Shields,Scott M. Berry,Todd Graves,Tim W. Malisch,Ansaar T Rai,Kevin N. Sheth,David S Liebeskind,Raul G Nogueira +21 more
TL;DR: To establish whether subjects considered to have substantial areas of salvageable brain based on age-adjusted clinical core mismatch who can undergo endovascular treatment within 6–24 h from time last seen well (TLSW) have better outcomes at three months compared to subjects treated with standard medical therapy alone.
Journal ArticleDOI
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative
Alexandra J. Lansky,Alexandra J. Lansky,Steven R. Messé,Adam M. Brickman,Michael G. Dwyer,H. Bart van der Worp,Ronald M. Lazar,Cody Pietras,Kevin J. Abrams,Eugene P. McFadden,Nils H Petersen,Jeffrey N. Browndyke,Bernard Prendergast,Vivian G. Ng,Donald E. Cutlip,Samir R. Kapadia,Mitchell W. Krucoff,Axel Linke,Claudia S. Moy,Joachim Schofer,Gerrit Anne van Es,Renu Virmani,Jeffrey J. Popma,Michael K. Parides,Susheel Kodali,Michel Bilello,Robert Zivadinov,Joseph G. Akar,Karen L. Furie,Daryl Gress,Szilard Voros,Jeffrey W. Moses,David M. Greer,John K. Forrest,David R. Holmes,Arie Pieter Kappetein,Michael J. Mack,Andreas Baumbach +37 more
TL;DR: The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions.
Journal ArticleDOI
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials
Alexandra J. Lansky,Alexandra J. Lansky,Steven R. Messé,Adam M. Brickman,Michael G. Dwyer,H. Bart van der Worp,Ronald M. Lazar,Cody Pietras,Kevin J. Abrams,Eugene P. McFadden,Nils H Petersen,Jeffrey N. Browndyke,Bernard Prendergast,Vivian G. Ng,Donald E. Cutlip,Samir R. Kapadia,Mitchell W. Krucoff,Axel Linke,Claudia S. Moy,Joachim Schofer,Gerrit Anne van Es,Renu Virmani,Jeffrey J. Popma,Michael K. Parides,Susheel Kodali,Michel Bilello,Robert Zivadinov,Joseph G. Akar,Karen L. Furie,Daryl Gress,Szilard Voros,Jeffrey W. Moses,David M. Greer,John K. Forrest,David R. Holmes,Arie Pieter Kappetein,Michael J. Mack,Andreas Baumbach +37 more
TL;DR: The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions.
Journal ArticleDOI
Evaluation of stroke incidence with duty-cycled multielectrode-phased radiofrequency ablation of persistent atrial fibrillation results of the VICTORY AF Study
John D. Hummel,Atul Verma,Hugh Calkins,Lee H. Schwamm,Daryl Gress,Darryl Wells,Joseph Souza,Robert B. Hokanson,Lauren Hemingway,Kurt Stromberg,Robert Hoyt,Andrew Wickliffe,David DeLurgio,Lucas V.A. Boersma +13 more
TL;DR: The VICTORY AF Study was designed to evaluate the risk of the procedure and/or device‐related strokes in patients with PersAF on warfarin undergoing ablation with a phased radiofrequency (RF) system.